Although most of the price-increasing varieties have started to "shift gears and slow down" at present, some medicinal materials affected by disasters and reduced production are still eager to rise. However, some varieties with previous price increases suddenly "lost contact" and some markets have "short circuit". With the increasing production of new medicinal materials in autumn and the arrival of the sales season, drug dealers still place more hopes on the future drug market.

In the face of the current high prices of most medicinal materials, what kind of varieties do you choose to buy? Make more drug dealers "I pull out my dagger, I peer four ways in vain". Although we all know that the wild medicinal materials such as Rhizoma Paridis, Rhizoma Bletillae, Polyporus, Scorpio, Leech, Sagittarius pilosa, Mylabris, etc. still have the potential to rise in the future, because the prices are already high, non-franchised households can only look up from a distance. Although the prices of wild varieties in Northeast China, such as Atractylodes lancea, Paeonia lactiflora and Dictamni Radicis, have dropped after new production this year, buyers are not interested in them because of the small drop and limited room for rebound.

At present, the price of most domestic medicinal materials has not reached the point where "cheap medicine hurts farmers", and the wind of planting medicines in various producing areas is still "high fever". In recent years, stimulated by the high income of planting medicinal materials, many large-scale contracted land plants have emerged, and medicinal materials planted in hundreds of acres and thousands of acres have blossomed everywhere, and local governments have also given financial support, which has enabled these medicinal materials to develop in a large area in new production areas. Such as: Pseudostellaria heterophylla, Atractylodes macrocephala, Angelica dahurica, Platycodon grandiflorum, Chrysanthemum morifolium, etc., there is not much expansion in the main producing areas, but a lot of planting in the new producing areas. The price of these medicinal materials seems to have been low in recent two years, but is there any chance to make money in the short term by buying and hoarding goods? Pseudostellaria heterophylla, since the high price of 100 yuan fell, how many people have really made money? How many people have hoarded Atractylodes macrocephala in 20 yuan in the past three years and made profits so far? This year, the price of platycodon grandiflorum has just entered a trough, and some drug dealers are eager to move, lest they can't buy low-priced goods. Platycodon grandiflorum is still a large area on the ground. Whether the production can be reduced or not, buying goods in advance may not necessarily mean "getting the moon first by being close to the water". Anemarrhena mollissima has been running in 7 yuan for more than three years, so far, there are not many profiters. Some varieties have just begun to slump, and the production will not be reduced. In the short term, I hope that the price increase can only be "looking at the flowers in the mirror and looking at the moon in the water".

Home-grown herbs such as Saposhnikovia divaricata, Pinellia ternata, Glehnia littoralis, Lily, Scutellaria baicalensis Georgi and Arctium lappa seem to have low prices, but they are only low prices, but not the bottom. It takes a long waiting process to buy goods in advance before the production is reduced in a large area. Menthol, since it fell from 400 yuan at a high price in 20 12, has entered several buyers at 200-220- yuan, 170- 180 yuan, 140- 150 yuan. Nowadays, the price of menthol has dropped to around 1 10 yuan, and the early buyers can only become stepping stones for the later buyers. The probability that the price of menthol will continue to decline is small, but it needs to be reduced in production and digested in stock to usher in a sunny spring.

At present, most domestic medicinal materials are in the downward adjustment stage, some are still looking for the "bottom" support point, and some are climbing from the bottom. It is best to be patient when business opportunities do not appear. Acting rashly and blindly following the trend are often not worth the loss. When we are at the end of our rope, it is not far from "a bright future".

At present, the Chinese herbal medicine market is in the stage of transformation, and e-commerce will become the future trading mode. At present, a large number of platforms such as Honeysuckle House have emerged. Whether it is a drug dealer who has been operating for more than ten years or just entered the drug market, he must keep up with the pace of development of the times.